Negative regulation by nuclear receptors: A plethora of mechanisms

Trends in Endocrinology and Metabolism

Volumn 22, Issue 3, 2011, Pages 87-93

  Santos, Guilherme M ^a   Fairall, Louise ^b   Schwabe, John W R ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 3; LIGAND; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROLACTIN; RECEPTOR INTERACTING PROTEIN 140; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; THYROTROPIN; TRANSCRIPTION FACTOR GATA 2;

DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; DNA; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, THYROID HORMONE; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVATION;

EID: 79952103416     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.11.004     Document Type: Review

References (56)

1. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
2. Hörlein A.J., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
3. Nagy L., Schwabe J.W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 2004, 29:317-324.
4. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
5. Sakai D.D., et al. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 1988, 2:1144-1154.
6. Chatterjee V.K., et al. Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:9114-9118.
7. Wondisford F.E., et al. Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J. Biol. Chem. 1989, 264:14601-14604.
8. Shibusawa N., et al. Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J. Biol. Chem. 2003, 278:732-738.
9. Shibusawa N., et al. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J. Clin. Invest. 2003, 112:588-597.
10. Subramaniam N., et al. Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. J. Biol. Chem. 1998, 273:23567-23574.
11. Villa A., et al. A response unit in the first exon of the beta-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3,5,3′-triiodothyronine. Mol. Endocrinol. 2004, 18:863-873.
12. Tagami T., et al. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J. Biol. Chem. 1999, 274:22345-22353.
13. Berghagen H., et al. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element. J. Biol. Chem. 2002, 277:49517-49522.
14. Ortiga-Carvalho T.M., et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J. Clin. Invest. 2005, 115:2517-2523.
15. Santos G.M., et al. Negative regulation of superoxide dismutase-1 promoter by thyroid hormone. Mol. Pharmacol. 2006, 70:793-800.
16. 3-regulated transcription of genes in vivo. Endocrinology 2002, 143:1346-1352.
17. Weiss R.E., et al. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 1999, 18:1900-1904.
18. Coste A., et al. Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. EMBO J. 2006, 25:2453-2464.
19. Rogatsky I., et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13845-13850.
20. Meijsing S.H., et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324:407-410.
21. Metzger E., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437:436-439.
22. I controls demethylation at histone H3K4. Nature 2010, 464:792-796.
23. Han S.J., et al. Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol. Metab. 2009, 20:8-15.
24. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 2007, 27:691-700.
25. Rosenfeld M.G., et al. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006, 20:1405-1428.
26. Wang C., et al. Acetylation in nuclear receptor signaling and the role of sirtuins. Mol. Endocrinol. 2008, 22:539-545.
27. You S.H., et al. The interaction between nuclear receptor corepressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 2010, 24:1359-1367.
28. Treuter E., et al. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 1998, 12:864-881.
29. Wei L.N., et al. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 2000, 275:40782-40787.
30. Christian M., et al. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol. Metab. 2006, 17:243-250.
31. Fernandes I., et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 2003, 11:139-150.
32. Yin L., Lazar M.A. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol. Endocrinol. 2005, 19:1452-1459.
33. Raghuram S., et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat. Struct. Mol. Biol. 2007, 14:1207-1213.
34. Potier N., et al. Using nondenaturing mass spectrometry to detect fortuitous ligands in orphan nuclear receptors. Protein Sci. 2003, 12:725-733.
35. Stehlin-Gaon C., et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol. 2003, 10:820-825.
36. Xu R.X., et al. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol. Cell 2004, 16:919-928.
37. Forman B.M., et al. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998, 395:612-615.
38. Dussault I., et al. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol. Cell Biol. 2002, 22:5270-5280.
39. Shan L., et al. Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol. Cell 2004, 16:907-917.
40. Adler S., et al. Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 1988, 52:685-695.
41. De Bosscher K., et al. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 2006, 25:6868-6886.
42. Reichardt H.M., et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93:531-541.
43. Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 2001, 20:2465-2475.
44. Diefenbacher M., et al. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol. Endocrinol. 2008, 22:1767-1780.
45. Heck S., et al. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 1997, 16:4698-4707.
46. Schüle R., et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990, 62:1217-1226.
47. Yang-Yen H.F., et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215.
48. Matsushita A., et al. Essential role of GATA2 in the negative regulation of thyrotropin beta gene by thyroid hormone and its receptors. Mol. Endocrinol. 2007, 21:865-884.
49. Figueira A.C., et al. Dissecting the relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHβ promoter. PLoS ONE 2010, 5:e12628.
50. Pascual G., et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 2005, 437:759-763.
51. Kininis M., Kraus W.L. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl. Recept. signaling 2008, 6:e005.
52. Lin C.Y., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3:e87.
53. So A.Y., et al. Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5745-5749.
54. Gill G., Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988, 334:721-724.
55. Wang Z., et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138:1019-1031.
56. Métivier R., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.